Common Activation of Canonical Wnt Signaling in Pancreatic Adenocarcinoma
2007

Wnt Signaling in Pancreatic Cancer

Sample size: 136 publication Evidence: moderate

Author Information

Author(s): Pasca di Magliano Marina, Biankin Andrew V., Heiser Patrick W., Cano David A., Gutierrez Pedro J. A., Deramaudt Therese, Segara Davendra, Dawson Amanda C., Kench James G., Henshall Susan M., Sutherland Robert L., Dlugosz Andrzej, Rustgi Anil K., Hebrok Matthias

Primary Institution: University of California at San Francisco

Hypothesis

The study investigates the activation of the canonical Wnt signaling pathway in pancreatic ductal adenocarcinoma (PDA) and its implications for cancer progression.

Conclusion

The study concludes that Wnt signaling is activated in pancreatic adenocarcinoma and plays a crucial role in cancer cell proliferation and survival.

Supporting Evidence

  • Wnt signaling was found to be activated in 65% of PDA samples.
  • Inhibition of Wnt signaling reduced cell proliferation and increased apoptosis in pancreatic cancer cell lines.
  • Hedgehog signaling was shown to activate Wnt signaling in pancreatic cancer models.

Takeaway

This study found that a signaling pathway called Wnt is turned on in pancreatic cancer, which helps the cancer cells grow and survive.

Methodology

The study used gene array analysis and immunohistochemistry to assess Wnt signaling activity in human PDA samples and mouse models.

Limitations

The study notes that the overall increases in Wnt signaling targets appear smaller than those observed in other tumors, which may limit the generalizability of the findings.

Participant Demographics

The study analyzed 136 human PDA samples and various pancreatic cancer cell lines.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1371/journal.pone.0001155

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication